Aims & Scope

Aims:

Cardiovascular Translation Research (CTR) is a peer-reviewed, international journal dedicated to advancing the field of cardiovascular science by bridging the gap between bench and bedside. The journal welcomes high-quality original research, reviews, and commentaries that focus on the translational continuum in cardiovascular medicine—from mechanistic and pre-clinical studies, through early human investigations, to clinical implementation and real-world outcomes. It is published quarterly online by Scilight Press.

Scope:

The mission of Cardiovascular Translation Research (CTR) is to accelerate the translation of scientific advances into improved cardiovascular health outcomes, by providing a forum for the dissemination and critical evaluation of translational research in cardiology.  It will include but not limit to the following topics:

  • Mechanistic insights into cardiovascular disease, including molecular, cellular, genetic, metabolic, haemodynamic and imaging-based studies.
  • Pre-clinical models (in vitro, ex vivo, in vivo) that test novel therapies, devices, diagnostics or biomarkers with clear translational intent.
  • First-in-man, pilot, feasibility and early phase clinical trials of novel cardiovascular interventions (therapeutic, diagnostic or preventive).
  • Studies addressing key translational hurdles: e.g., biomarker validation, device optimisation, imaging innovations, data-driven approaches, health-technology assessment, implementation science.
  • Reviews and commentaries that critically assess the path from experimental discovery to clinical adoption, including regulatory, ethical, health-economics and global-health aspects of cardiovascular translation.
  • Interdisciplinary work integrating cardiology, vascular biology, biomedical engineering, genomics, bioinformatics, artificial intelligence, regenerative medicine and population health.